nodes	percent_of_prediction	percent_of_DWPC	metapath
Vemurafenib—Basal cell carcinoma—Octreotide—thymus cancer	0.111	0.203	CcSEcCtD
Vemurafenib—VIIth nerve paralysis—Octreotide—thymus cancer	0.064	0.117	CcSEcCtD
Vemurafenib—Neoplasm malignant—Octreotide—thymus cancer	0.0308	0.056	CcSEcCtD
Vemurafenib—RAF1—neck—thymus cancer	0.0281	0.0725	CbGeAlD
Vemurafenib—BRAF—pituitary gland—thymus cancer	0.0233	0.0601	CbGeAlD
Vemurafenib—RAF1—hematopoietic system—thymus cancer	0.0209	0.054	CbGeAlD
Vemurafenib—BRAF—bone marrow—thymus cancer	0.0201	0.0519	CbGeAlD
Vemurafenib—BRAF—thyroid gland—thymus cancer	0.0201	0.0518	CbGeAlD
Vemurafenib—Arthritis—Octreotide—thymus cancer	0.0196	0.0357	CcSEcCtD
Vemurafenib—RAF1—epithelium—thymus cancer	0.0191	0.0493	CbGeAlD
Vemurafenib—Pain in extremity—Octreotide—thymus cancer	0.0191	0.0347	CcSEcCtD
Vemurafenib—BRAF—lung—thymus cancer	0.0182	0.047	CbGeAlD
Vemurafenib—Dry skin—Octreotide—thymus cancer	0.0175	0.0318	CcSEcCtD
Vemurafenib—RAF1—cardiac atrium—thymus cancer	0.0159	0.041	CbGeAlD
Vemurafenib—RAF1—pituitary gland—thymus cancer	0.0155	0.04	CbGeAlD
Vemurafenib—Weight decreased—Octreotide—thymus cancer	0.0149	0.0271	CcSEcCtD
Vemurafenib—RAF1—lymphoid tissue—thymus cancer	0.0147	0.038	CbGeAlD
Vemurafenib—ORM1—hematopoietic system—thymus cancer	0.0144	0.0373	CbGeAlD
Vemurafenib—Neuropathy peripheral—Octreotide—thymus cancer	0.0144	0.0262	CcSEcCtD
Vemurafenib—RAF1—bone marrow—thymus cancer	0.0134	0.0346	CbGeAlD
Vemurafenib—RAF1—thyroid gland—thymus cancer	0.0134	0.0345	CbGeAlD
Vemurafenib—Oedema peripheral—Octreotide—thymus cancer	0.013	0.0237	CcSEcCtD
Vemurafenib—BRAF—lymph node—thymus cancer	0.0125	0.0322	CbGeAlD
Vemurafenib—Cardiac disorder—Octreotide—thymus cancer	0.0122	0.0223	CcSEcCtD
Vemurafenib—RAF1—lung—thymus cancer	0.0122	0.0313	CbGeAlD
Vemurafenib—Alopecia—Octreotide—thymus cancer	0.0117	0.0212	CcSEcCtD
Vemurafenib—Malnutrition—Octreotide—thymus cancer	0.0115	0.0209	CcSEcCtD
Vemurafenib—Erythema—Octreotide—thymus cancer	0.0115	0.0209	CcSEcCtD
Vemurafenib—Back pain—Octreotide—thymus cancer	0.0111	0.0202	CcSEcCtD
Vemurafenib—Cough—Octreotide—thymus cancer	0.01	0.0182	CcSEcCtD
Vemurafenib—Myalgia—Octreotide—thymus cancer	0.00978	0.0178	CcSEcCtD
Vemurafenib—Arthralgia—Octreotide—thymus cancer	0.00978	0.0178	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00971	0.0177	CcSEcCtD
Vemurafenib—Anaphylactic shock—Octreotide—thymus cancer	0.00937	0.0171	CcSEcCtD
Vemurafenib—Infection—Octreotide—thymus cancer	0.00931	0.0169	CcSEcCtD
Vemurafenib—ORM1—bone marrow—thymus cancer	0.00926	0.0239	CbGeAlD
Vemurafenib—Nervous system disorder—Octreotide—thymus cancer	0.00919	0.0167	CcSEcCtD
Vemurafenib—Skin disorder—Octreotide—thymus cancer	0.0091	0.0166	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00854	0.0155	CcSEcCtD
Vemurafenib—ORM1—lung—thymus cancer	0.00839	0.0216	CbGeAlD
Vemurafenib—CYP1A2—hematopoietic system—thymus cancer	0.00833	0.0215	CbGeAlD
Vemurafenib—RAF1—lymph node—thymus cancer	0.00831	0.0214	CbGeAlD
Vemurafenib—Decreased appetite—Octreotide—thymus cancer	0.00815	0.0148	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Octreotide—thymus cancer	0.00809	0.0147	CcSEcCtD
Vemurafenib—Fatigue—Octreotide—thymus cancer	0.00808	0.0147	CcSEcCtD
Vemurafenib—Constipation—Octreotide—thymus cancer	0.00801	0.0146	CcSEcCtD
Vemurafenib—ABCC1—cardiac atrium—thymus cancer	0.00794	0.0205	CbGeAlD
Vemurafenib—ABCC1—pituitary gland—thymus cancer	0.00775	0.02	CbGeAlD
Vemurafenib—Body temperature increased—Octreotide—thymus cancer	0.00741	0.0135	CcSEcCtD
Vemurafenib—Hypersensitivity—Octreotide—thymus cancer	0.0069	0.0126	CcSEcCtD
Vemurafenib—Asthenia—Octreotide—thymus cancer	0.00672	0.0122	CcSEcCtD
Vemurafenib—ABCC1—thyroid gland—thymus cancer	0.00668	0.0172	CbGeAlD
Vemurafenib—Pruritus—Octreotide—thymus cancer	0.00663	0.0121	CcSEcCtD
Vemurafenib—ABCG2—pituitary gland—thymus cancer	0.00642	0.0166	CbGeAlD
Vemurafenib—Diarrhoea—Octreotide—thymus cancer	0.00641	0.0117	CcSEcCtD
Vemurafenib—Dizziness—Octreotide—thymus cancer	0.0062	0.0113	CcSEcCtD
Vemurafenib—ABCC1—lung—thymus cancer	0.00607	0.0157	CbGeAlD
Vemurafenib—CYP3A4—hematopoietic system—thymus cancer	0.00603	0.0156	CbGeAlD
Vemurafenib—Vomiting—Octreotide—thymus cancer	0.00596	0.0108	CcSEcCtD
Vemurafenib—CYP2D6—hematopoietic system—thymus cancer	0.00593	0.0153	CbGeAlD
Vemurafenib—Rash—Octreotide—thymus cancer	0.00591	0.0108	CcSEcCtD
Vemurafenib—Dermatitis—Octreotide—thymus cancer	0.0059	0.0107	CcSEcCtD
Vemurafenib—Headache—Octreotide—thymus cancer	0.00587	0.0107	CcSEcCtD
Vemurafenib—ORM1—lymph node—thymus cancer	0.00574	0.0148	CbGeAlD
Vemurafenib—Nausea—Octreotide—thymus cancer	0.00557	0.0101	CcSEcCtD
Vemurafenib—ABCG2—bone marrow—thymus cancer	0.00555	0.0143	CbGeAlD
Vemurafenib—ABCG2—thyroid gland—thymus cancer	0.00553	0.0143	CbGeAlD
Vemurafenib—CYP1A2—thyroid gland—thymus cancer	0.00533	0.0137	CbGeAlD
Vemurafenib—ALB—lymph node—thymus cancer	0.00503	0.013	CbGeAlD
Vemurafenib—ABCG2—lung—thymus cancer	0.00503	0.013	CbGeAlD
Vemurafenib—CYP1A2—lung—thymus cancer	0.00484	0.0125	CbGeAlD
Vemurafenib—ABCC1—lymph node—thymus cancer	0.00415	0.0107	CbGeAlD
Vemurafenib—ABCG2—lymph node—thymus cancer	0.00344	0.00887	CbGeAlD
Vemurafenib—BRAF—Neuronal System—KCNA4—thymus cancer	0.00261	0.0413	CbGpPWpGaD
Vemurafenib—RAF1—Neuronal System—KCNA4—thymus cancer	0.0018	0.0286	CbGpPWpGaD
Vemurafenib—BRAF—Bladder Cancer—CDKN2A—thymus cancer	0.00167	0.0264	CbGpPWpGaD
Vemurafenib—BRAF—Downstream signaling in naïve CD8+ T cells—CD8A—thymus cancer	0.00149	0.0237	CbGpPWpGaD
Vemurafenib—RAF1—Axon guidance—DPYSL5—thymus cancer	0.00143	0.0226	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signaling in naïve CD8+ T cells—CD8A—thymus cancer	0.00103	0.0164	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—DPYSL5—thymus cancer	0.00102	0.0161	CbGpPWpGaD
Vemurafenib—BRAF—Estrogen signaling pathway—AKT1—thymus cancer	0.000994	0.0158	CbGpPWpGaD
Vemurafenib—RAF1—Signaling events mediated by Stem cell factor receptor (c-Kit)—KIT—thymus cancer	0.000953	0.0151	CbGpPWpGaD
Vemurafenib—BRAF—Bladder Cancer—TP53—thymus cancer	0.000927	0.0147	CbGpPWpGaD
Vemurafenib—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—thymus cancer	0.000859	0.0136	CbGpPWpGaD
Vemurafenib—RAF1—Kit receptor signaling pathway—KIT—thymus cancer	0.000849	0.0134	CbGpPWpGaD
Vemurafenib—RAF1—IL-5 Signaling Pathway—IL2—thymus cancer	0.000815	0.0129	CbGpPWpGaD
Vemurafenib—RAF1—TCR Signaling Pathway—CD8A—thymus cancer	0.000806	0.0128	CbGpPWpGaD
Vemurafenib—BRAF—Downstream signaling in naïve CD8+ T cells—IL2—thymus cancer	0.000789	0.0125	CbGpPWpGaD
Vemurafenib—RAF1—IL-2 Signaling Pathway—IL2—thymus cancer	0.000784	0.0124	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways in Glioblastoma—CDKN2A—thymus cancer	0.000765	0.0121	CbGpPWpGaD
Vemurafenib—RAF1—Interleukin-2 signaling—IL2—thymus cancer	0.000716	0.0113	CbGpPWpGaD
Vemurafenib—RAF1—IL2-mediated signaling events—IL2—thymus cancer	0.000641	0.0102	CbGpPWpGaD
Vemurafenib—RAF1—Regulation of retinoblastoma protein—CDKN2A—thymus cancer	0.00063	0.00998	CbGpPWpGaD
Vemurafenib—BRAF—Senescence and Autophagy in Cancer—CDKN2A—thymus cancer	0.000628	0.00995	CbGpPWpGaD
Vemurafenib—RAF1—EPO Receptor Signaling—AKT1—thymus cancer	0.000624	0.00988	CbGpPWpGaD
Vemurafenib—RAF1—SHP2 signaling—IL2—thymus cancer	0.000605	0.00959	CbGpPWpGaD
Vemurafenib—RAF1—FSH signaling pathway—AKT1—thymus cancer	0.000605	0.00959	CbGpPWpGaD
Vemurafenib—BRAF—Corticotropin-releasing hormone—IL2—thymus cancer	0.000605	0.00958	CbGpPWpGaD
Vemurafenib—RAF1—IGF1 pathway—AKT1—thymus cancer	0.000556	0.00881	CbGpPWpGaD
Vemurafenib—RAF1—Extracellular vesicle-mediated signaling in recipient cells—AKT1—thymus cancer	0.000556	0.00881	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by FGFR—KIT—thymus cancer	0.000547	0.00866	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signaling in naïve CD8+ T cells—IL2—thymus cancer	0.000546	0.00865	CbGpPWpGaD
Vemurafenib—RAF1—Nongenotropic Androgen signaling—AKT1—thymus cancer	0.000542	0.00859	CbGpPWpGaD
Vemurafenib—ABCG2—Fluoropyrimidine Activity—TP53—thymus cancer	0.000532	0.00843	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways in Glioblastoma—CDKN2A—thymus cancer	0.000529	0.00839	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by FGFR in disease—KIT—thymus cancer	0.000509	0.00807	CbGpPWpGaD
Vemurafenib—RAF1—Class I PI3K signaling events mediated by Akt—AKT1—thymus cancer	0.000492	0.00779	CbGpPWpGaD
Vemurafenib—RAF1—TCR Signaling Pathway—CD4—thymus cancer	0.000463	0.00734	CbGpPWpGaD
Vemurafenib—RAF1—CXCR3-mediated signaling events—AKT1—thymus cancer	0.00046	0.00729	CbGpPWpGaD
Vemurafenib—BRAF—NGF signalling via TRKA from the plasma membrane—KIT—thymus cancer	0.000451	0.00715	CbGpPWpGaD
Vemurafenib—RAF1—IL-5 Signaling Pathway—AKT1—thymus cancer	0.000442	0.007	CbGpPWpGaD
Vemurafenib—RAF1—Senescence and Autophagy in Cancer—CDKN2A—thymus cancer	0.000434	0.00688	CbGpPWpGaD
Vemurafenib—RAF1—ErbB2/ErbB3 signaling events—AKT1—thymus cancer	0.000433	0.00686	CbGpPWpGaD
Vemurafenib—BRAF—TSH signaling pathway—AKT1—thymus cancer	0.000428	0.00678	CbGpPWpGaD
Vemurafenib—BRAF—mTOR signaling pathway—AKT1—thymus cancer	0.000428	0.00678	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways in Glioblastoma—TP53—thymus cancer	0.000426	0.00675	CbGpPWpGaD
Vemurafenib—RAF1—IL-2 Signaling Pathway—AKT1—thymus cancer	0.000425	0.00673	CbGpPWpGaD
Vemurafenib—RAF1—TWEAK Signaling Pathway—AKT1—thymus cancer	0.000425	0.00673	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by SCF-KIT—KIT—thymus cancer	0.000423	0.0067	CbGpPWpGaD
Vemurafenib—RAF1—Corticotropin-releasing hormone—IL2—thymus cancer	0.000419	0.00663	CbGpPWpGaD
Vemurafenib—BRAF—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—thymus cancer	0.000418	0.00662	CbGpPWpGaD
Vemurafenib—RAF1—Interleukin-11 Signaling Pathway—AKT1—thymus cancer	0.000409	0.00649	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signaling of activated FGFR—KIT—thymus cancer	0.000404	0.00641	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB4—KIT—thymus cancer	0.000398	0.00631	CbGpPWpGaD
Vemurafenib—RAF1—Ceramide signaling pathway—AKT1—thymus cancer	0.000382	0.00605	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signal transduction—KIT—thymus cancer	0.00038	0.00602	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR—KIT—thymus cancer	0.000378	0.00599	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB2—KIT—thymus cancer	0.000376	0.00596	CbGpPWpGaD
Vemurafenib—RAF1—IL-3 Signaling Pathway—AKT1—thymus cancer	0.000376	0.00595	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 signaling—KIT—thymus cancer	0.000375	0.00593	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—CYLD—thymus cancer	0.000373	0.00591	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by Interleukins—IL2—thymus cancer	0.000368	0.00583	CbGpPWpGaD
Vemurafenib—RAF1—Signaling events mediated by Stem cell factor receptor (c-Kit)—AKT1—thymus cancer	0.000364	0.00576	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways in Glioblastoma—AKT1—thymus cancer	0.00036	0.0057	CbGpPWpGaD
Vemurafenib—RAF1—Oncostatin M Signaling Pathway—TP53—thymus cancer	0.000355	0.00562	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 interactions—KIT—thymus cancer	0.000352	0.00558	CbGpPWpGaD
Vemurafenib—RAF1—Fc epsilon receptor (FCERI) signaling—KIT—thymus cancer	0.000352	0.00558	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR in disease—KIT—thymus cancer	0.000352	0.00558	CbGpPWpGaD
Vemurafenib—BRAF—Senescence and Autophagy in Cancer—TP53—thymus cancer	0.000349	0.00554	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR—KIT—thymus cancer	0.000349	0.00553	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by NGF—KIT—thymus cancer	0.000347	0.0055	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR in Cancer—KIT—thymus cancer	0.000346	0.00548	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by PDGF—KIT—thymus cancer	0.000345	0.00546	CbGpPWpGaD
Vemurafenib—RAF1—Cardiac Hypertrophic Response—AKT1—thymus cancer	0.000343	0.00543	CbGpPWpGaD
Vemurafenib—BRAF—Corticotropin-releasing hormone—AKT1—thymus cancer	0.000328	0.0052	CbGpPWpGaD
Vemurafenib—RAF1—Kit receptor signaling pathway—AKT1—thymus cancer	0.000324	0.00513	CbGpPWpGaD
Vemurafenib—RAF1—Fc-epsilon receptor I signaling in mast cells—AKT1—thymus cancer	0.000315	0.005	CbGpPWpGaD
Vemurafenib—BRAF—B Cell Receptor Signaling Pathway—AKT1—thymus cancer	0.000314	0.00498	CbGpPWpGaD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—KIT—thymus cancer	0.000312	0.00494	CbGpPWpGaD
Vemurafenib—RAF1—Endothelins—AKT1—thymus cancer	0.000307	0.00487	CbGpPWpGaD
Vemurafenib—BRAF—Integrin-mediated Cell Adhesion—AKT1—thymus cancer	0.000307	0.00486	CbGpPWpGaD
Vemurafenib—RAF1—Oncostatin M Signaling Pathway—AKT1—thymus cancer	0.0003	0.00475	CbGpPWpGaD
Vemurafenib—RAF1—AGE/RAGE pathway—AKT1—thymus cancer	0.000296	0.00469	CbGpPWpGaD
Vemurafenib—RAF1—mTOR signaling pathway—AKT1—thymus cancer	0.000296	0.00469	CbGpPWpGaD
Vemurafenib—RAF1—TSH signaling pathway—AKT1—thymus cancer	0.000296	0.00469	CbGpPWpGaD
Vemurafenib—BRAF—ErbB1 downstream signaling—AKT1—thymus cancer	0.000295	0.00468	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways in Glioblastoma—TP53—thymus cancer	0.000295	0.00467	CbGpPWpGaD
Vemurafenib—ALB—Folate Metabolism—IL2—thymus cancer	0.000294	0.00466	CbGpPWpGaD
Vemurafenib—RAF1—BCR signaling pathway—AKT1—thymus cancer	0.000292	0.00463	CbGpPWpGaD
Vemurafenib—RAF1—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—thymus cancer	0.000289	0.00458	CbGpPWpGaD
Vemurafenib—RAF1—Retinoblastoma (RB) in Cancer—TP53—thymus cancer	0.000281	0.00445	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—thymus cancer	0.000274	0.00435	CbGpPWpGaD
Vemurafenib—RAF1—Leptin signaling pathway—AKT1—thymus cancer	0.000267	0.00423	CbGpPWpGaD
Vemurafenib—BRAF—Integrated Breast Cancer Pathway—TP53—thymus cancer	0.000261	0.00414	CbGpPWpGaD
Vemurafenib—ABCG2—HIF-1-alpha transcription factor network—AKT1—thymus cancer	0.000258	0.00409	CbGpPWpGaD
Vemurafenib—RAF1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—AKT1—thymus cancer	0.000254	0.00402	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways in Glioblastoma—AKT1—thymus cancer	0.000249	0.00394	CbGpPWpGaD
Vemurafenib—RAF1—MicroRNAs in cardiomyocyte hypertrophy—AKT1—thymus cancer	0.000244	0.00387	CbGpPWpGaD
Vemurafenib—RAF1—Senescence and Autophagy in Cancer—TP53—thymus cancer	0.000242	0.00383	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—KIT—thymus cancer	0.00024	0.0038	CbGpPWpGaD
Vemurafenib—BRAF—MAPK Signaling Pathway—TP53—thymus cancer	0.00024	0.0038	CbGpPWpGaD
Vemurafenib—RAF1—TCR Signaling Pathway—AKT1—thymus cancer	0.000231	0.00366	CbGpPWpGaD
Vemurafenib—BRAF—Disease—MAML2—thymus cancer	0.000231	0.00365	CbGpPWpGaD
Vemurafenib—RAF1—Corticotropin-releasing hormone—AKT1—thymus cancer	0.000227	0.0036	CbGpPWpGaD
Vemurafenib—RAF1—TNF alpha Signaling Pathway—AKT1—thymus cancer	0.000227	0.0036	CbGpPWpGaD
Vemurafenib—BRAF—Integrated Breast Cancer Pathway—AKT1—thymus cancer	0.000221	0.0035	CbGpPWpGaD
Vemurafenib—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—thymus cancer	0.00022	0.00349	CbGpPWpGaD
Vemurafenib—RAF1—B Cell Receptor Signaling Pathway—AKT1—thymus cancer	0.000218	0.00345	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CYLD—thymus cancer	0.000217	0.00345	CbGpPWpGaD
Vemurafenib—RAF1—Integrin-mediated Cell Adhesion—AKT1—thymus cancer	0.000212	0.00336	CbGpPWpGaD
Vemurafenib—BRAF—EGF/EGFR Signaling Pathway—AKT1—thymus cancer	0.000209	0.00331	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by FGFR—AKT1—thymus cancer	0.000209	0.00331	CbGpPWpGaD
Vemurafenib—RAF1—Platelet activation, signaling and aggregation—IL2—thymus cancer	0.000208	0.00329	CbGpPWpGaD
Vemurafenib—RAF1—ErbB1 downstream signaling—AKT1—thymus cancer	0.000204	0.00324	CbGpPWpGaD
Vemurafenib—BRAF—MAPK Signaling Pathway—AKT1—thymus cancer	0.000203	0.00321	CbGpPWpGaD
Vemurafenib—RAF1—TGF-beta Signaling Pathway—TP53—thymus cancer	0.000201	0.00319	CbGpPWpGaD
Vemurafenib—RAF1—VEGFA-VEGFR2 Pathway—AKT1—thymus cancer	0.000201	0.00319	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by FGFR in disease—AKT1—thymus cancer	0.000194	0.00308	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by VEGF—AKT1—thymus cancer	0.00019	0.00301	CbGpPWpGaD
Vemurafenib—ALB—Folate Metabolism—TP53—thymus cancer	0.000189	0.00299	CbGpPWpGaD
Vemurafenib—BRAF—Focal Adhesion—AKT1—thymus cancer	0.000184	0.00291	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—CD8A—thymus cancer	0.000175	0.00277	CbGpPWpGaD
Vemurafenib—BRAF—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	0.000172	0.00273	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—IL2—thymus cancer	0.000172	0.00272	CbGpPWpGaD
Vemurafenib—RAF1—TGF-beta Signaling Pathway—AKT1—thymus cancer	0.00017	0.00269	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—TP53—thymus cancer	0.000166	0.00263	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—MAML2—thymus cancer	0.000161	0.00256	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by SCF-KIT—AKT1—thymus cancer	0.000161	0.00256	CbGpPWpGaD
Vemurafenib—RAF1—Disease—MAML2—thymus cancer	0.000159	0.00253	CbGpPWpGaD
Vemurafenib—RAF1—BDNF signaling pathway—AKT1—thymus cancer	0.000159	0.00251	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—MAML2—thymus cancer	0.000158	0.0025	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signaling of activated FGFR—AKT1—thymus cancer	0.000154	0.00245	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB4—AKT1—thymus cancer	0.000152	0.00241	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	0.00015	0.00237	CbGpPWpGaD
Vemurafenib—RAF1—Insulin Signaling—AKT1—thymus cancer	0.000146	0.00231	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signal transduction—AKT1—thymus cancer	0.000145	0.0023	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR—AKT1—thymus cancer	0.000144	0.00229	CbGpPWpGaD
Vemurafenib—RAF1—EGF/EGFR Signaling Pathway—AKT1—thymus cancer	0.000144	0.00229	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB2—AKT1—thymus cancer	0.000144	0.00228	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 signaling—AKT1—thymus cancer	0.000143	0.00226	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—AKT1—thymus cancer	0.00014	0.00222	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—KIT—thymus cancer	0.000137	0.00217	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR in disease—AKT1—thymus cancer	0.000134	0.00213	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 interactions—AKT1—thymus cancer	0.000134	0.00213	CbGpPWpGaD
Vemurafenib—RAF1—Fc epsilon receptor (FCERI) signaling—AKT1—thymus cancer	0.000134	0.00213	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR—AKT1—thymus cancer	0.000133	0.00211	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by NGF—AKT1—thymus cancer	0.000132	0.0021	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR in Cancer—AKT1—thymus cancer	0.000132	0.00209	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by PDGF—AKT1—thymus cancer	0.000131	0.00208	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—KIT—thymus cancer	0.000131	0.00208	CbGpPWpGaD
Vemurafenib—RAF1—Focal Adhesion—AKT1—thymus cancer	0.000127	0.00201	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	0.000127	0.002	CbGpPWpGaD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	0.000119	0.00189	CbGpPWpGaD
Vemurafenib—RAF1—Platelet activation, signaling and aggregation—AKT1—thymus cancer	0.000113	0.00178	CbGpPWpGaD
Vemurafenib—ALB—Platelet activation, signaling and aggregation—IL2—thymus cancer	0.000112	0.00177	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—MAML2—thymus cancer	0.000112	0.00177	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—IL2—thymus cancer	0.000107	0.0017	CbGpPWpGaD
Vemurafenib—BRAF—Disease—KIT—thymus cancer	0.000106	0.00169	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CD8A—thymus cancer	0.000106	0.00168	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—CD4—thymus cancer	0.000105	0.00166	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—CD4—thymus cancer	0.000101	0.00159	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—AKT1—thymus cancer	9.16e-05	0.00145	CbGpPWpGaD
Vemurafenib—BRAF—Disease—CD4—thymus cancer	8.14e-05	0.00129	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—KIT—thymus cancer	7.97e-05	0.00126	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—KIT—thymus cancer	7.45e-05	0.00118	CbGpPWpGaD
Vemurafenib—RAF1—Disease—KIT—thymus cancer	7.36e-05	0.00117	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—KIT—thymus cancer	7.3e-05	0.00116	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—TP53—thymus cancer	6.87e-05	0.00109	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—IL2—thymus cancer	6.14e-05	0.000973	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CD4—thymus cancer	6.1e-05	0.000966	CbGpPWpGaD
Vemurafenib—ALB—Platelet activation, signaling and aggregation—AKT1—thymus cancer	6.06e-05	0.00096	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—AKT1—thymus cancer	5.92e-05	0.000937	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—AKT1—thymus cancer	5.8e-05	0.000919	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—IL2—thymus cancer	5.76e-05	0.000913	CbGpPWpGaD
Vemurafenib—RAF1—Disease—CD4—thymus cancer	5.63e-05	0.000892	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IL2—thymus cancer	5.61e-05	0.000889	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—CD4—thymus cancer	5.58e-05	0.000884	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—IL2—thymus cancer	5.24e-05	0.000831	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—AKT1—thymus cancer	5.22e-05	0.000828	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—KIT—thymus cancer	5.16e-05	0.000817	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—AKT1—thymus cancer	5.02e-05	0.000795	CbGpPWpGaD
Vemurafenib—BRAF—Disease—AKT1—thymus cancer	4.06e-05	0.000643	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—TP53—thymus cancer	3.7e-05	0.000586	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—IL2—thymus cancer	3.63e-05	0.000575	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—TP53—thymus cancer	3.37e-05	0.000534	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—AKT1—thymus cancer	3.33e-05	0.000528	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—AKT1—thymus cancer	3.12e-05	0.000495	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—AKT1—thymus cancer	3.04e-05	0.000482	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—AKT1—thymus cancer	2.84e-05	0.000451	CbGpPWpGaD
Vemurafenib—RAF1—Disease—AKT1—thymus cancer	2.81e-05	0.000445	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—AKT1—thymus cancer	2.78e-05	0.000441	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—AKT1—thymus cancer	2.33e-05	0.00037	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—TP53—thymus cancer	2.33e-05	0.000369	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—AKT1—thymus cancer	2.05e-05	0.000325	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—AKT1—thymus cancer	1.97e-05	0.000312	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—AKT1—thymus cancer	1.27e-05	0.000201	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—AKT1—thymus cancer	1.05e-05	0.000166	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—AKT1—thymus cancer	8.86e-06	0.00014	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—AKT1—thymus cancer	6.84e-06	0.000108	CbGpPWpGaD
